Saturday , December 5 2020

In 10 years, 15% of diabetics have been added, with growth over time becoming unrealistic

Update: 07.11.2018 18:21

Prague – In the last 10 years, 15% of diabetics were treated, last year almost 930,000. Other people are not yet aware of the diagnosis. The treatment of these patients is about 13 percent of the total cost of health care, averaging 53,000 crowns per patient. The information given today was given at the Press Conference of the Czech Association of Pharmaceutical Companies (ČAFF) for World Diabetes Day, which is celebrated on November 14th.

About 90% of diabetics have diabetes of the second type, which is half genetically modified and the other half is an unhealthy lifestyle. According to DiaVize diabetes head, diabetes Marty Klement, 30 minutes of physical exercise, including walking or gardening, reduces the risk of diabetes by one-third.

For type 2 diabetes, the body has an excess of insulin that can not be released as quickly as the patient needs. In addition, their own insulin does not work as is the so-called insulin resistance.

Last year, about 33 billion crowns were spent on second-class diabetes in the Czech Republic, with a total of about 300 billion in health care. If the number of diabetics had risen at the same rate as before, in 2035 every ten Czechs will suffer. "Continuous growth will become unrealistic over time," Klement added.

Patients typically receive a combination of up to four drugs for diabetes, another for blood pressure or high cholesterol. "Patients are not treated with a combination of ten drugs because if they do not follow the diet, their glycemia will not be normal," said Klement, saying that the cost of working with the patient and his lifestyle is much lower and often more effective than healing. More than a third of them do not follow doctors' treatment.

The Czech Diabetes Society supports patient education. Studies show that group treatments are even more effective than individual discussions with the patient. From next year, according to Clement, health insurance companies will also pay. "The problem is to get the patients there, but if they return, they return more often than regular checks," he added.

The patient changing his lifestyle can achieve such an improvement that he will not need to take so many medicines and will be cheaper for the health system. Martin Mátl, director of the ČAFF, is also trying to save the cost of public health insurance by introducing so-called generic medicines, a copy of the original medicines that have resulted in the protection of patents. An example is the medicine of metformin, which is used by most diabetics. Over the last ten years, according to Math, the generic has earned 3.7 billion kronor.

In addition, diabetics do not only treat symptoms that are directly related to diabetes, but more often suffer from chronic complications such as heart disease and renal failure. The risk of a stroke increases diabetes by two to four times, five times infarction, heart failure or coronary artery disease.





Source link